Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / COM
-
Number of holders
-
231
-
Total 13F shares, excl. options
-
55.6M
-
Shares change
-
-4.28M
-
Total reported value, excl. options
-
$4.77B
-
Value change
-
-$321M
-
Put/Call ratio
-
0.61
-
Number of buys
-
115
-
Number of sells
-
-110
-
Price
-
$85.71
Significant Holders of Biohaven Pharmactl Hldg Co L - COM (BHVN) as of Q4 2020
297 filings reported holding BHVN - Biohaven Pharmactl Hldg Co L - COM as of Q4 2020.
Biohaven Pharmactl Hldg Co L - COM (BHVN) has 231 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 55.6M shares
.
Largest 10 shareholders include Capital International Investors (5.33M shares), Capital World Investors (4.65M shares), BlackRock Inc. (3.52M shares), MARSHALL WACE, LLP (2.56M shares), STIFEL FINANCIAL CORP (2.54M shares), ORACLE INVESTMENT MANAGEMENT INC (2.15M shares), RP Management, LLC (2.11M shares), EVENTIDE ASSET MANAGEMENT, LLC (1.78M shares), JPMORGAN CHASE & CO (1.68M shares), and STATE STREET CORP (1.67M shares).
This table shows the top 231 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.